Literature DB >> 11511981

Hsal 1 is related to kidney and gonad development and is expressed in Wilms tumor.

Y Ma1, D B Singer, A Gozman, D Ford, L Chai, M M Steinhoff, K Hansen, A L Maizel.   

Abstract

Townes-Brocks syndrome (TBS) is a human genetic disorder with features including urogenital, limb, anal and cardiac malformations associated with mutations of the TBS gene, Hsal 1. To begin to understand the role of the Hsal 1 protein (p140) in both normal development and disease pathogenesis, both message and protein expression were evaluated in specific tissues associated with TBS. DNA sequence information for Hsal 1 predicts that this homeotic, Drosophila homologue (Sal) encodes a zinc-finger protein consistent with a transcription factor. mRNA for Hsal 1 was highly expressed in fetal kidney and brain, with detectable production in thymus and heart. p140 was found in fetal ureteric bud, fetal and postnatal renal tubular epithelium, and renal blastema. In the 14-week fetal testis, the Hsal 1 protein was specifically expressed in the testosterone producing Leydig cells while in adult gonads Hsal 1 was also found in both Leydig and Sertoli cells, spermatogonia of the testis, and granulosa cells of the ovary. Evaluation of Wilms tumor revealed consistently high expression of the gene product in the epithelial and blastemal components. These spatial and temporal patterns of expression for Hsal 1, and the phenotypic effects associated with TBS, suggest that Hsal 1 plays an important role in the development and functional maintenance of the kidney and gonads. Furthermore, the Hsal 1 gene product may play a part in the pathogenesis of specific neoplasms occurring in these organs in addition to its specific role in Townes-Brocks syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511981     DOI: 10.1007/s004670100624

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

Review 1.  The role of stem cell factor SALL4 in leukemogenesis.

Authors:  Chong Gao; Nikki R Kong; Li Chai
Journal:  Crit Rev Oncog       Date:  2011

2.  Immunoexpression of SALL4 in Wilms tumors and developing kidney.

Authors:  Jeremy Deisch; Jack Raisanen; Dinesh Rakheja
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

3.  SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.

Authors:  Yupo Ma; Wei Cui; Jianchang Yang; Jun Qu; Chunhui Di; Hesham M Amin; Raymond Lai; Jerome Ritz; Diane S Krause; Li Chai
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

4.  Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.

Authors:  Chi-Ming Li; Meirong Guo; Alain Borczuk; Charles A Powell; Michelle Wei; Harshwardhan M Thaker; Richard Friedman; Ulf Klein; Benjamin Tycko
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

5.  Drosophila spalt/spalt-related mutants exhibit Townes-Brocks' syndrome phenotypes.

Authors:  P D Si Dong; Sokol V Todi; Daniel F Eberl; Grace Boekhoff-Falk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

6.  Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.

Authors:  Carlos Farkas; Carla P Martins; David Escobar; Matias I Hepp; Ariel F Castro; Gerard Evan; José L Gutiérrez; Robert Warren; David B Donner; Roxana Pincheira
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

7.  Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.

Authors:  Jiayun Lu; Ha-Won Jeong; Hawon Jeong; Nikki Kong; Youyang Yang; John Carroll; Hongbo R Luo; Leslie E Silberstein; Li Chai
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

8.  SALL1 expression in acute myeloid leukemia.

Authors:  Huda Salman; Xiao Shuai; Anh Thu Nguyen-Lefebvre; Banabihari Giri; Mingqiang Ren; Michael Rauchman; Lynn Robbins; Wei Hou; Hasan Korkaya; Yupo Ma
Journal:  Oncotarget       Date:  2017-12-15

9.  Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer.

Authors:  Kiyoshi Misawa; Yuki Misawa; Atsushi Imai; Daiki Mochizuki; Shiori Endo; Masato Mima; Ryuji Ishikawa; Hideya Kawasaki; Takashi Yamatodani; Takeharu Kanazawa
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

Review 10.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.